Apr 7, 2023, 12:07 by

Apr 7, 2023, 12:07 by

Apr 7, 2023, 12:06 by

Alfa Chemistry, known as a chemical supplier for various high-quality chemicals and materials for both academia and the industry, has recently extended its offering scope to vaccine related products, including but not limited to: vaccine excipients, nucleic acid delivery excipients, cell culture media and pharmaceutical packaging.

Apr 6, 2023, 10:39 by

PCR Biosystems has launched the VeriFi™ Library Amplification Mix, combining the powerful and robust proofreading performance of VeriFi™ Hot Start Polymerase with a greatly reduced GC-dependent bias.

Apr 6, 2023, 10:38 by

Todaro Robotics, Inc has announced a major milestone with its flagship client Abwiz Bio, Inc a company that speeds up the development of high impact monoclonal antibodies with its proprietary phage display technology. up the development of

Apr 6, 2023, 01:01 by User Not Found

Clinical Research News | Circulating tumor DNA (ctDNA) holds potential as a biomarker in lung cancer clinical trials as an added and easier-to-monitor endpoint to survival rates for measuring treatment efficacy. This was one of the key findings of her most recent work, where ctDNA was also shown to outperform clinical responses assessed on CT scans in the prediction of survival.

Apr 5, 2023, 11:07 by

Apr 5, 2023, 11:06 by

CluePoints Announces Amit Patel as New CFO Organizational changes support rapid growth, scale, and focus for RBQM leader

Apr 4, 2023, 11:34 by

Apr 4, 2023, 11:31 by

Apr 4, 2023, 11:31 by

Apr 4, 2023, 11:27 by

Abzena, the leading end-to-end integrated CDMO for complex biologic molecules and Antibody Drug Conjugates (ADCs) has announced the appointment of Sean O’Brien as Senior Vice President and Site Head at its San Diego facility.

Apr 4, 2023, 09:23 by User Not Found

Clinical Research News | Su Golder, associate professor and senior research fellow in the Department of Health Sciences at the University of York, speaks with the Scope of Things podcast host Deborah Borfitz about adverse event reporting and the challenges that hinder its consistent practice in the health sciences community.

Apr 3, 2023, 11:30 by

TransCure bioServices has announced two new additions to their team, with the aim of further enhancing the care given to their animals while reinforcing their well-established animal welfare policy.

Apr 3, 2023, 11:30 by

CureSearch announced a newly-funded Phase I clinical trial led by Dr. David Munn of the Medical College of Georgia at Augusta University. Funded through a CureSearch Catapult Award, Dr. Munn is working to bring new therapies to brain cancer patients.

Apr 3, 2023, 11:29 by

Apr 3, 2023, 11:23 by

Apr 3, 2023, 11:23 by

Apr 3, 2023, 11:22 by

MediMergent, a leading Real-World Data (RWD) and Evidence (RWE) company, announced the implementation of its digital clinical trials platform for the collection and analysis of RWD in a large multicenter study entitled EIMPRIS (Engaging Immuno-Protection Intervention Study) focused on the prevention of symptomatic SARS-CoV-2 infection in cancer patients.

Mar 31, 2023, 09:49 by

A newly released market research reports on the prosperous future of exosome research.